nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamterene—Azotaemia—Mechlorethamine—lymphatic system cancer	0.1	0.1	CcSEcCtD
Triamterene—Anaemia megaloblastic—Methotrexate—lymphatic system cancer	0.0434	0.0434	CcSEcCtD
Triamterene—Azotaemia—Carmustine—lymphatic system cancer	0.0415	0.0415	CcSEcCtD
Triamterene—Azotaemia—Vincristine—lymphatic system cancer	0.0396	0.0396	CcSEcCtD
Triamterene—Hyperkalaemia—Fludarabine—lymphatic system cancer	0.0339	0.0339	CcSEcCtD
Triamterene—Jaundice—Mechlorethamine—lymphatic system cancer	0.029	0.029	CcSEcCtD
Triamterene—Hyperkalaemia—Mitoxantrone—lymphatic system cancer	0.0202	0.0202	CcSEcCtD
Triamterene—Blood urea increased—Mitoxantrone—lymphatic system cancer	0.0194	0.0194	CcSEcCtD
Triamterene—Azotaemia—Methotrexate—lymphatic system cancer	0.0192	0.0192	CcSEcCtD
Triamterene—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.019	0.019	CcSEcCtD
Triamterene—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.0186	0.0186	CcSEcCtD
Triamterene—Renal failure acute—Mitoxantrone—lymphatic system cancer	0.0161	0.0161	CcSEcCtD
Triamterene—Hypokalaemia—Carmustine—lymphatic system cancer	0.0146	0.0146	CcSEcCtD
Triamterene—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.014	0.014	CcSEcCtD
Triamterene—Thrombocytopenia—Teniposide—lymphatic system cancer	0.0137	0.0137	CcSEcCtD
Triamterene—Hypokalaemia—Mitoxantrone—lymphatic system cancer	0.0136	0.0136	CcSEcCtD
Triamterene—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.013	0.013	CcSEcCtD
Triamterene—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.0123	0.0123	CcSEcCtD
Triamterene—Vomiting—Mechlorethamine—lymphatic system cancer	0.0121	0.0121	CcSEcCtD
Triamterene—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.0121	0.0121	CcSEcCtD
Triamterene—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.0121	0.0121	CcSEcCtD
Triamterene—Rash—Mechlorethamine—lymphatic system cancer	0.012	0.012	CcSEcCtD
Triamterene—Dermatitis—Mechlorethamine—lymphatic system cancer	0.012	0.012	CcSEcCtD
Triamterene—Nausea—Mechlorethamine—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Triamterene—Jaundice—Mitoxantrone—lymphatic system cancer	0.0112	0.0112	CcSEcCtD
Triamterene—Fatigue—Fludarabine—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Triamterene—Hypersensitivity—Teniposide—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Triamterene—Asthenia—Teniposide—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Triamterene—Diarrhoea—Teniposide—lymphatic system cancer	0.00958	0.00958	CcSEcCtD
Triamterene—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00907	0.00907	CcSEcCtD
Triamterene—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00903	0.00903	CcSEcCtD
Triamterene—Vomiting—Teniposide—lymphatic system cancer	0.00891	0.00891	CcSEcCtD
Triamterene—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00884	0.00884	CcSEcCtD
Triamterene—Asthenia—Fludarabine—lymphatic system cancer	0.00883	0.00883	CcSEcCtD
Triamterene—Rash—Teniposide—lymphatic system cancer	0.00883	0.00883	CcSEcCtD
Triamterene—Dermatitis—Teniposide—lymphatic system cancer	0.00882	0.00882	CcSEcCtD
Triamterene—Headache—Teniposide—lymphatic system cancer	0.00878	0.00878	CcSEcCtD
Triamterene—Photosensitivity—Methotrexate—lymphatic system cancer	0.00846	0.00846	CcSEcCtD
Triamterene—Diarrhoea—Fludarabine—lymphatic system cancer	0.00842	0.00842	CcSEcCtD
Triamterene—Nausea—Teniposide—lymphatic system cancer	0.00832	0.00832	CcSEcCtD
Triamterene—Renal failure acute—Methotrexate—lymphatic system cancer	0.00804	0.00804	CcSEcCtD
Triamterene—Vomiting—Fludarabine—lymphatic system cancer	0.00783	0.00783	CcSEcCtD
Triamterene—Rash—Fludarabine—lymphatic system cancer	0.00776	0.00776	CcSEcCtD
Triamterene—Dermatitis—Fludarabine—lymphatic system cancer	0.00776	0.00776	CcSEcCtD
Triamterene—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00771	0.00771	CcSEcCtD
Triamterene—Headache—Fludarabine—lymphatic system cancer	0.00771	0.00771	CcSEcCtD
Triamterene—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00752	0.00752	CcSEcCtD
Triamterene—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00736	0.00736	CcSEcCtD
Triamterene—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00733	0.00733	CcSEcCtD
Triamterene—Nausea—Fludarabine—lymphatic system cancer	0.00731	0.00731	CcSEcCtD
Triamterene—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00717	0.00717	CcSEcCtD
Triamterene—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00665	0.00665	CcSEcCtD
Triamterene—Fatigue—Vincristine—lymphatic system cancer	0.00649	0.00649	CcSEcCtD
Triamterene—Asthenia—Bleomycin—lymphatic system cancer	0.00648	0.00648	CcSEcCtD
Triamterene—Fatigue—Mitoxantrone—lymphatic system cancer	0.00632	0.00632	CcSEcCtD
Triamterene—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00586	0.00586	CcSEcCtD
Triamterene—Hypersensitivity—Carmustine—lymphatic system cancer	0.00581	0.00581	CcSEcCtD
Triamterene—Vomiting—Bleomycin—lymphatic system cancer	0.00574	0.00574	CcSEcCtD
Triamterene—Rash—Bleomycin—lymphatic system cancer	0.00569	0.00569	CcSEcCtD
Triamterene—Dermatitis—Bleomycin—lymphatic system cancer	0.00569	0.00569	CcSEcCtD
Triamterene—Asthenia—Carmustine—lymphatic system cancer	0.00565	0.00565	CcSEcCtD
Triamterene—Hypersensitivity—Vincristine—lymphatic system cancer	0.00554	0.00554	CcSEcCtD
Triamterene—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.0054	0.0054	CcSEcCtD
Triamterene—Asthenia—Vincristine—lymphatic system cancer	0.0054	0.0054	CcSEcCtD
Triamterene—Diarrhoea—Carmustine—lymphatic system cancer	0.00539	0.00539	CcSEcCtD
Triamterene—Nausea—Bleomycin—lymphatic system cancer	0.00536	0.00536	CcSEcCtD
Triamterene—Asthenia—Mitoxantrone—lymphatic system cancer	0.00526	0.00526	CcSEcCtD
Triamterene—Dizziness—Carmustine—lymphatic system cancer	0.00521	0.00521	CcSEcCtD
Triamterene—Diarrhoea—Vincristine—lymphatic system cancer	0.00515	0.00515	CcSEcCtD
Triamterene—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00501	0.00501	CcSEcCtD
Triamterene—Vomiting—Carmustine—lymphatic system cancer	0.00501	0.00501	CcSEcCtD
Triamterene—Dizziness—Vincristine—lymphatic system cancer	0.00497	0.00497	CcSEcCtD
Triamterene—Rash—Carmustine—lymphatic system cancer	0.00497	0.00497	CcSEcCtD
Triamterene—Dermatitis—Carmustine—lymphatic system cancer	0.00496	0.00496	CcSEcCtD
Triamterene—Headache—Carmustine—lymphatic system cancer	0.00494	0.00494	CcSEcCtD
Triamterene—Vomiting—Vincristine—lymphatic system cancer	0.00478	0.00478	CcSEcCtD
Triamterene—Rash—Vincristine—lymphatic system cancer	0.00474	0.00474	CcSEcCtD
Triamterene—Dermatitis—Vincristine—lymphatic system cancer	0.00474	0.00474	CcSEcCtD
Triamterene—Headache—Vincristine—lymphatic system cancer	0.00471	0.00471	CcSEcCtD
Triamterene—Nausea—Carmustine—lymphatic system cancer	0.00468	0.00468	CcSEcCtD
Triamterene—Vomiting—Mitoxantrone—lymphatic system cancer	0.00466	0.00466	CcSEcCtD
Triamterene—Rash—Mitoxantrone—lymphatic system cancer	0.00462	0.00462	CcSEcCtD
Triamterene—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00461	0.00461	CcSEcCtD
Triamterene—Headache—Mitoxantrone—lymphatic system cancer	0.00459	0.00459	CcSEcCtD
Triamterene—Nausea—Vincristine—lymphatic system cancer	0.00447	0.00447	CcSEcCtD
Triamterene—Nausea—Mitoxantrone—lymphatic system cancer	0.00435	0.00435	CcSEcCtD
Triamterene—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00365	0.00365	CcSEcCtD
Triamterene—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Triamterene—Fatigue—Methotrexate—lymphatic system cancer	0.00315	0.00315	CcSEcCtD
Triamterene—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Triamterene—Asthenia—Methotrexate—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Triamterene—Diarrhoea—Methotrexate—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Triamterene—Dizziness—Methotrexate—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Triamterene—Vomiting—Methotrexate—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Triamterene—Rash—Methotrexate—lymphatic system cancer	0.0023	0.0023	CcSEcCtD
Triamterene—Dermatitis—Methotrexate—lymphatic system cancer	0.0023	0.0023	CcSEcCtD
Triamterene—Headache—Methotrexate—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Triamterene—Nausea—Methotrexate—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
